Show simple item record

dc.contributor.authorBroughton, Trevor
dc.contributor.authorMillward, Tim
dc.contributor.authorGeelan, Steve
dc.date.accessioned2017-09-20T15:57:33Z
dc.date.available2017-09-20T15:57:33Z
dc.date.issued2012
dc.identifier.citationBroughton, T., Millward, T. & Geelan, S. (2012). A case report of clozapine augmentation with granulocyte colony stimulating factor (G-CSF). Journal of Forensic Psychiatry and Psychology, 23 (1), pp.125-133.
dc.identifier.other10.1080/14789949.2011.633096
dc.identifier.urihttps://repository.nottinghamshirehealthcare.nhs.uk/handle/123456789/1328
dc.description.abstractFor some patients clozapine represents the only option for controlling the debilitating symptoms of schizophrenia. More tragic are those cases where previously successful treatment with clozapine is withdrawn as a result of blood dyscrasia. In this article, the authors describe such a case. In this instance it was possible to continue treatment with clozapine to good effect by using granulocyte colony stimulating factor (G-CSF) as an adjunct. This article further explores the decision-making process and the clinical evidence behind this approach. © 2012 Copyright Taylor and Francis Group, LLC.
dc.description.urihttp://www.tandfonline.com/doi/full/10.1080/14789949.2011.633096
dc.subjectDrug therapy
dc.subjectLeukocyte disorders
dc.titleA case report of clozapine augmentation with granulocyte colony stimulating factor (G-CSF)
dc.typeArticle


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record